Torsemide Pregnancy and Breastfeeding Warnings
Torsemide is also known as: Demadex, Demadex IV
Medically reviewed on February 13, 2017
Torsemide Pregnancy Warnings
Animal studies revealed evidence of fetotoxicity at doses that produced maternal toxicity. There are no controlled data in human pregnancy.
US FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
Use is considered contraindicated and should be used during pregnancy only if clearly needed.
US FDA pregnancy category: B
Torsemide Breastfeeding Warnings
UK: Use is contraindicated.
US: Caution is recommended.
Excreted into human milk: Unknown
Excreted into animal milk: Unknown
Comments: The effects in the nursing infant are unknown.
References for pregnancy information
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- "Product Information. Demedex (torsemide)." Boehringer Mannheim, Gaithersburg, MD.
References for breastfeeding information
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- "Product Information. Demedex (torsemide)." Boehringer Mannheim, Gaithersburg, MD.
See Also...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
